Abstract:ABSTRACT With its estrogenic activity, ( S )-equol plays an important role in maintaining host health and preventing estrogen-related diseases. Exclusive production occurs through the transformation of soy isoflavones by intestinal bacteria, but the reasons for variations in ( S )-equol production among different individuals and species remain unclear. Here, fecal samples from humans, pigs, chickens, mice, and rats were used as research objects. The concentrations of ( S )-equol, along with the genetic homology and evolutionary relationships of ( S )-equol production-related genes [daidzein reductase (DZNR), daidzein racemase (DDRC), dihydrodaidzein reductase (DHDR), tetrahydrodaidzein reductase (THDR)], were analyzed. Additionally, in vitro functional verification of the newly identified DDRC gene was conducted. It was found that approximately 40% of human samples contained ( S )-equol, whereas 100% of samples from other species contained ( S )-equol. However, there were significant variations in ( S)- equol content among the different species: rats > pigs > chickens > mice > humans. The distributions of the four genes displayed species-specific patterns. High detection rates across various species were exhibited by DHDR , THDR , and DDRC . In contrast, substantial variations in detection rates among different species and individuals were observed with respect to DZNR . It appears that various types of DZNR may be associated with different concentrations of ( S)- equol, which potentially correspond to the regulatory role during ( S)- equol synthesis. This enhances our understanding of individual variations in ( S )-equol production and their connection with functional genes in vitro . Moreover, the newly identified DDRC exhibits higher potential for ( S)- equol synthesis compared to the known DDRC, providing valuable resources for advancing in vitro ( S)- equol production. IMPORTANCE ( S )-equol (( S )-EQ) plays a crucial role in maintaining human health, along with its known capacity to prevent and treat various diseases, including cardiovascular diseases, metabolic syndromes, osteoporosis, diabetes, brain-related diseases, high blood pressure, hyperlipidemia, obesity, and inflammation. However, factors affecting individual variations in ( S )-EQ production and the underlying regulatory mechanisms remain elusive. This study examines the association between functional genes and ( S )-EQ production, highlighting a potential correlation between the DZNR gene and ( S )-EQ content. Various types of DZNR may be linked to the regulation of ( S )-EQ synthesis. Furthermore, the identification of a new DDRC gene offers promising prospects for enhancing in vitro ( S )-EQ production.

In vitro culture reveals the conversion of daidzein to equol by fecal microflora of Erhualian pigs

Isolation and Identification of Equol-Producing Bacterial Strains from Cultures of Pig Faeces.

[Microbial Conversion of Daidzein Affects Fecal Equol Concentration and Bacterial Composition of Rats with or Without Ovariectomy].

Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows

Individual Difference in Faecal and Urine Equol Excretion and Their Correlation with Intestinal Microbiota in Large White Sows

EFFECT OF DAIDZEIN ON THE INTESTINAL FLORA OF PIGLETS

Lactulose Increases Equol Production and Improves Liver Antioxidant Status in Barrows Treated with Daidzein.

To Construct an Engineered (S)-Equol Resistant E. Coli for in Vitro (S)-Equol Production

Daidzein Intake Is Associated with Equol Producing Status through an Increase in the Intestinal Bacteria Responsible for Equol Production

Exploring functional genes’ correlation with ( S )-equol concentration and new daidzein racemase identification

Development and Use of a Real-Time Quantitative PCR Method for Detecting and Quantifying Equol-Producing Bacteria in Human Faecal Samples and Slurry Cultures

The Production of Equol by Mixed Culture Fermentation of Streptococcus Faecium and Enterobacter

Supplementation of difructose anhydride III enhanced elevation of plasma equol concentrations and lowered plasma total cholesterol in isoflavone-fed rats

Application of recombinant lactic acid bacteria and bifidobacteria able to enrich soy beverage in dihydrodaidzein and dihydrogenistein

Effects of Equol Supplementation on Growth Performance, Redox Status, Intestinal Health and Skeletal Muscle Development of Weanling Piglets with Intrauterine Growth Retardation

[Equol: a Metabolite of Soy Isoflavones by Intestinal Microflora--a Review].

Metabolism of Dietary Soy Isoflavones to Equol by Human Intestinal Microflora – Implications for Health

Effect of Fermented Soy Beverage on Equol Production by Fecal Microbiota

Characterization and identification of a novel daidzein reductase involved in (S)-equol biosynthesis in Clostridium C1

Characterization and Identification of a New Daidzein Reductase Involved in (S)-Equol Biosynthesis in Clostridium Sp. ZJ6

Comparative Analysis of Fecal Microbiota Between Diarrhea and Non-Diarrhea Piglets Reveals Biomarkers of Gut Microbiota Associated with Diarrhea